MK-5442
Drug timelines are a Plus or Pro feature.
2 regulatory and trial events tracked for MK-5442, covering 2012-10-10 to 2012-11-16. Get the full timeline:
Most recent: Clinical Trial Update: MK-5442 in the Treatment of Osteoporosis in Postmenopausal Women Previously Treated With an Oral Bisphosphonate (MK-5442-012) [Phase 2]